Lexeo Therapeutics, Inc. (LXEO) Tops Q1 EPS by 49c
Tweet
Share
E-mailGet Alerts LXEO Hot Sheet
Join SI Premium – FREE
Lexeo Therapeutics, Inc. (NASDAQ: LXEO) reported Q1 EPS of ($0.25), $0.49 better than the analyst estimate of ($0.74). Revenue for the quarter came in at $0.
For earnings history and earnings-related data on Lexeo Therapeutics, Inc. (LXEO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Robinhood Ventures Fund II opens at $22.50, IPO at $25
- Sandisk targets mid-to-high teens revenue growth through FY2030
- UBS Reiterates Buy Rating on Sysco (SYY) Following Trip to Company Headquarters
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
